Jul 27, 2023 7:00am EDT NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
Jul 18, 2023 7:10am EDT NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
Jun 29, 2023 7:00am EDT NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
Jun 15, 2023 4:45pm EDT NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage